Wikipedia -WSS

Wikipedia

author：explore 2025-10-02 18:48:28 - browse：9

TRENTON, N.J. — Pharma industry giants including Bristol Myers Squibb, Johnson & Johnson, Novartis, and Novo Nordisk deployed a half-dozen lawyers to a courtroom here Thursday in a bid to dismantle Medicare’s new drug price negotiation program, just hours before President Biden is set to glorify it in his State of the Union.

A federal judge in New Jersey heard an unusual quadruple oral argument in which attorneys for all four drugmakers combined forces to challenge different facets of the Inflation Reduction Act, which in 2022 empowered Medicare to negotiate the prices of a small number of drugs each year beginning in 2026.

Over four hours, the debate spanned most of the substantive issues that pharmaceutical companies and their allies have raised across the country, both in constitutional challenges to the law and in challenges to how Medicare officials have interpreted the law so far. That means the court’s decision in these cases could produce a first substantive test for several of the arguments that haven’t been addressed by courts in other states, where companies like Boehringer Ingelheim, AstraZeneca, and Merck are also suing, separately, over the same law.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Medicare to cover more brain scans for Alzheimer’s patients

knowledge

WSS

Medicare to cover more brain scans for Alzheimer’s patients

Hearing on Medicare drug price negotiation gets unusually heated

Readout LOUD podcast: possible new ALS drug, artificial wombs

How AI helped researchers track recovery from depression

Medicare has a new plan to address drug shortages

How dance can help nurses traumatized by Covid

hotspot

Wikipedia

leisure time

Walensky prepares to leave CDC — and Congress — behind

WHO calls for emergency meeting on new China virus, as cases spread

At least 13 dead in Texas as scorching temps continue

FDA panel to weigh approval of NurOwn, controversial ALS drug

In Memoriam: Notable people who died in 2023

How AI helped researchers track recovery from depression

Medicare details structure of new drug price negotiation program

FDA moves to stop vape shops from selling Elf Bar, Esco Bars

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

As digital health tech proliferates, a new institute aims to cut through hype

hotspot

Lasker Awards 2023: Winners in biomedical research

Group opposing PBM reform sets lobbying record

At Orexo, a ‘turning point’ for everything but digital health

Lasker Awards 2023: Winners in biomedical research

Drug for rare kidney disease narrowly misses mark in clinical trial

Microbiome research is starting to find links to chronic diseases

hotspot

knowledge

knowledge

knowledge